A service of StreetInsider.com
Ticker Symbol
Welcome

Most Popular

AAPL 493.17
C 33.66
GOOG 611.46
BAC 8.18
RIMM 15.90

Recently Added

CPIC 1.19
SHMX 0.00
NBTH 12.50
COHO 0.00
PZZI 4.71

Gaining Speed

COHO 0.00
SHMX 0.00
CPIC 1.19
NBTH 12.50
AVEW 0.00
8.80 -0.09 (-1.01%) SHP

Click Here to Receive Instant E-mail and RSS Alerts


Trade SHP now with

Stock Details

Last Trade:8.80 Change:-0.09 (-1.01%) Prev Close:8.89 Open: 8.90 Days Range:8.80 – 8.97 52 Week Range: 7.23 - 13.39 Volume:9300 P/E: N/A
EPS:0.00

Member Comments

No member comments available for SHP


Not logged in - Log in or Sign up to leave comments





View AllRecent Alerts 02/10/12

Recent Alert on 02/09/12 at 7:16am
ShangPharma Corp. (SHP) Misses Q4 EPS by 4c

ShangPharma Corp. (NYSE: SHP) reported Q4 EPS of $1.33, $0.04 worse than the analyst estimate of $1.37. Revenue for the quarter came in at $1.14 billion versus the consensus estimate of $1.13 billion. For earnings history and earnings-related... Read More

Recent Alert on 01/19/12 at 8:04am
ShangPharma (SHP) Receives First Milestone in Research Partnership with Hengrui
Recent Alert on 12/12/11 at 8:03am
ShangPharma Corporation (SHP) Announces Resignation of Chief Operating Officer, Mr. Kevin Chen
Recent Alert on 11/22/11 at 8:18am
Oppenheimer Maintains an 'Outperform' on ShangPharma (SHP); 3Q11: In-Line Quarter; Margin Pressure Should Ease Once Utilization Ramps Up
Recent Alert on 11/21/11 at 6:30am
ShangPharma Corp. (SHP) Reports In-Line Q3 EPS

View AllRecent Press Releases

Press Release on 02/09/12 at 7:00am
Another Strong Year for Shire With Revenues Exceeding $4 Billion for the First Time and Non GAAP EPS up 26% to $5.34
Press Release on 02/07/12 at 12:37pm
Vyvanse® (lisdexamfetamine dimesylate) Capsules, (CII) Now Approved in the US for Maintenance Treatment in Adults with ADHD
Press Release on 02/07/12 at 12:15pm
Vyvanse(R) (lisdexamfetamine dimesylate) Capsules, (CII) Now Approved in the US for Maintenance Treatment in Adults with ADHD

View AllRecent SEC Filings

SEC Filing on 02/09/12 at 10:06am
Form SC 13G/A ShangPharma Corp Filed by: Hui Michael Xin

View AllRecent Blog Posts

Blog Posts on 02/05/12 at 6:28am
The Week In Review: Are WuXi PharmaTech And ShangPharma Takeover Targets?
Blog Posts on 02/02/12 at 12:56pm
Are WuXi PharmaTech and ShangPharma M&A Targets?
Blog Posts on 12/11/11 at 2:13am
20 Biotech Stocks That Hedge Funds Are Selling
Blog Posts on 11/02/11 at 5:08am
Equal Energy: An Unparalleled Opportunity
Blog Posts on 10/30/11 at 5:35am
China Biotech Week In Review: BioBay Park Forms Partnership With Roche, Harvard